TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/4/24 18:09 | 6/3/24 | VOR | Vor Biopharma Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Attar Eyal C. | MA | O | Chief Me | S | -20 | 1.39 | 0 | -15 | -13 | 96 | D | ||||||||||||||
3/1/22 17:01 | 2/28/22 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Attar Eyal C. | MA | O | SVP,Chie | S | -62 | 1.73 | 0 | -36 | -43 | 47 | D | ||||||||||||||
9/20/21 17:29 | 9/16/21 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Attar Eyal C. | MA | O | SVP,Chie | S | -75 | 4.68 | 0 | -16 | -16 | 83 | D | ||||||||||||||
10/7/19 19:18 | 10/7/19 | APRE | Aprea Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Attar Eyal C. | MA | O | SVP,Chie | P.d | 6 | 15.00 | 0 | 0 | New | 0 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |